01 October 2018

Life sciences sector: Industry insight and global experience: the intelligent connection

Life sciences companies are constantly under scrutiny, but it is most intense when shareholders, business partners or regulators suspect wrongdoing. Regulators and enforcement agencies are more joined up than ever before as they cooperate across borders in the fight against fraud, bribery and corruption. This demands increasingly higher levels of integrity, honesty and transparency in the way life sciences companies operate and makes it more critical than ever to respond rapidly, appropriately and robustly to any aberrational conduct. By making the intelligent connection between your business operations, markets and third-party relationships, EY can help you get to the root cause of problems resulting from impropriety. 

Document ID: 2018-6141